Cleviprex
Cleviprex is a medicine authorised by Swissmedic under authorisation number 60117. The authorisation holder is Chiesi SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 June 2010 and the authorisation is valid without a time limit. ATC code C08CA16 places the medicine in the group Calcium channel blockers.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Cleviprex, emulsion pour perfusion | B | 05 June 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 10 x 50 ml | Durchstechflasche(n) | C08CA16 | 02.06.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cleviprex authorised in Switzerland?
Yes. Cleviprex is authorised by Swissmedic under authorisation number 60117, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cleviprex have?
Cleviprex is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cleviprex?
The authorisation holder is Chiesi SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.